Company Filing History:
Years Active: 2001
Title: Micael A Guillot: Innovator in Pharmaceutical Formulations
Introduction
Micael A Guillot is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on poorly soluble drug substances. His innovative work has led to the development of methods that enhance the delivery of these challenging compounds.
Latest Patents
Micael A Guillot holds a patent for "Pharmaceutical formulations containing poorly soluble drug substances." This patent describes a method for preparing pharmaceutical formulations in the form of concentrated solutions for filling soft gelatin capsules, as well as solid dispersions and suspensions for filling hard gelatin capsules and compressing into tablets. The formulations include the sodium salt of the poorly soluble drug substance, along with various conversion aids such as PEG, polysorbate, and sugar alcohols like mannitol or xylitol. Additionally, it may include excipients such as dicalcium phosphate dihydrate, lactose monohydrate, or microcrystalline cellulose.
Career Highlights
Micael A Guillot is associated with Sanofi-Synthelabo, a leading global healthcare company. His work at Sanofi-Synthelabo has allowed him to focus on innovative solutions in the pharmaceutical industry, particularly in enhancing the solubility and bioavailability of drug substances.
Collaborations
Micael has collaborated with esteemed colleagues, including Nancy M Franson and Sharon M Laughlin. These partnerships have contributed to the advancement of pharmaceutical formulations and the development of effective drug delivery systems.
Conclusion
Micael A Guillot's contributions to pharmaceutical formulations demonstrate his commitment to improving drug delivery methods. His innovative patent and collaborations highlight his role as a key figure in the field of pharmaceuticals.